NOTCH1 and acute lymphoblastic leukemia: It will come as no surprise that this study confirms the high frequency of recurrent NOTCH1 mutations (69% of cases) in T‐ALL, second only to CDKN2A alterations (71% of cases), with the majority being coding sequence mutations that lead to activation of NOTCH1 signaling.